29% Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate Get link Facebook X Pinterest Email Other Apps GlobeNewswire Get link Facebook X Pinterest Email Other Apps